Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FCGRT | P55899 | 4/20 | 0.80 |
| ▸ | EPHA2 | P29317 | 11/20 | 0.47 |
| ▸ | ACE | P12821 | 2/20 | 0.44 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.44 |
| ▸ | MC4R | P32245 | 1/20 | 0.43 |
| ▸ | MC3R | P41968 | 1/20 | 0.43 |
| ▸ | MC1R | Q01726 | 1/20 | 0.43 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.42 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.42 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.41 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.41 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12305037 | 0.89 | FCGRT (0.81) | FCGRTEPHA2ACEACE2MC4R | |
| SCHEMBL10132153 | 0.88 | FCGRT (0.64) | FCGRTEPHA2ACEACE2KEAP1 | |
| SCHEMBL12253738 | 0.86 | FCGRT (0.66) | FCGRTEPHA2ACEACE2KEAP1 | |
| SCHEMBL12766288 | 0.86 | FCGRT (0.66) | FCGRTEPHA2ACEACE2KEAP1 | |
| SCHEMBL12253644 | 0.77 | FCGRT (0.62) | FCGRTEPHA2ACEACE2MC4R | |
| SCHEMBL24625820 | 0.65 | KLK7 (0.53) | EPHA2ACEACE2 | |
| SCHEMBL24625791 | 0.64 | EPHA2 (0.51) | FCGRTEPHA2ACEACE2 | |
| SCHEMBL26880160 | 0.64 | F11 (0.57) | MC4RMC3RMC1R | |
| SCHEMBL26902265 | 0.63 | F11 (0.57) | MC4RMC3RMC1R | |
| SCHEMBL24625831 | 0.63 | SSTR2 (0.56) | FCGRTEPHA2ACEACE2KEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070254831-A1 | PEPTIDES THAT BLOCK THE BINDING OF IgG to FcRn | BIOGEN HEMOPHILIA INC. | 2007-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070254831-A1 | PEPTIDES THAT BLOCK THE BINDING OF IgG to FcRn | FCGRT, FCGR3B, FCGR1A | FCGRT 1/4885EPHA2 920/4885ACE 1806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.